232 related articles for article (PubMed ID: 35844793)
1. miR-199a-3p/5p regulate tumorgenesis via targeting Rheb in non-small cell lung cancer.
Liu X; Wang X; Chai B; Wu Z; Gu Z; Zou H; Zhang H; Li Y; Sun Q; Fang W; Ma Z
Int J Biol Sci; 2022; 18(10):4187-4202. PubMed ID: 35844793
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-199a-5p Induced Autophagy and Inhibits the Pathogenesis of Ankylosing Spondylitis by Modulating the mTOR Signaling via Directly Targeting Ras Homolog Enriched in Brain (Rheb).
Wang Y; Luo J; Wang X; Yang B; Cui L
Cell Physiol Biochem; 2017; 42(6):2481-2491. PubMed ID: 28848090
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-193a-3p and -5p suppress the metastasis of human non-small-cell lung cancer by downregulating the ERBB4/PIK3R3/mTOR/S6K2 signaling pathway.
Yu T; Li J; Yan M; Liu L; Lin H; Zhao F; Sun L; Zhang Y; Cui Y; Zhang F; Li J; He X; Yao M
Oncogene; 2015 Jan; 34(4):413-23. PubMed ID: 24469061
[TBL] [Abstract][Full Text] [Related]
4. Dysregulated
Sui J; Zhao Q; Zhang Y; Liang G
DNA Cell Biol; 2022 Mar; 41(3):319-329. PubMed ID: 35244469
[TBL] [Abstract][Full Text] [Related]
5. microRNA-145-3p inhibits non-small cell lung cancer cell migration and invasion by targeting PDK1 via the mTOR signaling pathway.
Chen GM; Zheng AJ; Cai J; Han P; Ji HB; Wang LL
J Cell Biochem; 2018 Jan; 119(1):885-895. PubMed ID: 28661070
[TBL] [Abstract][Full Text] [Related]
6. Licochalcone A restrains microphthalmia-associated transcription factor expression and growth by activating autophagy in melanoma cells via miR-142-3p/Rheb/mTOR pathway.
Zhang Y; Gao M; Chen L; Zhou L; Bian S; Lv Y
Phytother Res; 2020 Feb; 34(2):349-358. PubMed ID: 31793097
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-199a-3p suppresses glioma cell proliferation by regulating the AKT/mTOR signaling pathway.
Shen L; Sun C; Li Y; Li X; Sun T; Liu C; Zhou Y; Du Z
Tumour Biol; 2015 Sep; 36(9):6929-38. PubMed ID: 25854175
[TBL] [Abstract][Full Text] [Related]
8. Using biological information to analyze potential miRNA-mRNA regulatory networks in the plasma of patients with non-small cell lung cancer.
Zhang W; Zhang Q; Che L; Xie Z; Cai X; Gong L; Li Z; Liu D; Liu S
BMC Cancer; 2022 Mar; 22(1):299. PubMed ID: 35313857
[TBL] [Abstract][Full Text] [Related]
9. circ_0007385 served as competing endogenous RNA for miR-519d-3p to suppress malignant behaviors and cisplatin resistance of non-small cell lung cancer cells.
Ye Y; Zhao L; Li Q; Xi C; Li Y; Li Z
Thorac Cancer; 2020 Aug; 11(8):2196-2208. PubMed ID: 32602212
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic silencing of miR-483-3p promotes acquired gefitinib resistance and EMT in EGFR-mutant NSCLC by targeting integrin β3.
Yue J; Lv D; Wang C; Li L; Zhao Q; Chen H; Xu L
Oncogene; 2018 Aug; 37(31):4300-4312. PubMed ID: 29717264
[TBL] [Abstract][Full Text] [Related]
11. MiR-200c-3p and miR-485-5p overexpression elevates cisplatin sensitivity and suppresses the malignant phenotypes of non-small cell lung cancer cells through targeting RRM2.
Liu Y; Zhang Y; Li Q; Xu R; Huang N
Thorac Cancer; 2022 Jul; 13(13):1974-1985. PubMed ID: 35599447
[TBL] [Abstract][Full Text] [Related]
12. miR-199a-5p and miR-495 target GRP78 within UPR pathway of lung cancer.
Ahmadi A; Khansarinejad B; Hosseinkhani S; Ghanei M; Mowla SJ
Gene; 2017 Jul; 620():15-22. PubMed ID: 28363780
[TBL] [Abstract][Full Text] [Related]
13. CHML targeted by miR-199a-3p promotes non-small cell lung cancer cell growth via binding to Rab5A.
Dong C; Cao H; Liu Z; Xi L; Shi Y; Yang R
Pathol Res Pract; 2021 Nov; 227():153626. PubMed ID: 34649053
[TBL] [Abstract][Full Text] [Related]
14. Hsa-miR-125a-3p and hsa-miR-125a-5p are downregulated in non-small cell lung cancer and have inverse effects on invasion and migration of lung cancer cells.
Jiang L; Huang Q; Zhang S; Zhang Q; Chang J; Qiu X; Wang E
BMC Cancer; 2010 Jun; 10():318. PubMed ID: 20569443
[TBL] [Abstract][Full Text] [Related]
15. [Impacts of LncRNA NORAD on the Proliferation, Apoptosis, and Chemosensitivity of Non-small Cell Lung Cancer Cells by Regulating ZNF217 through MiR-199a-3p].
Gao Y; Luo X; Liao P; Luo Y
Zhongguo Fei Ai Za Zhi; 2023 Jul; 26(7):479-486. PubMed ID: 37653011
[TBL] [Abstract][Full Text] [Related]
16. Cytological effects of honokiol treatment and its potential mechanism of action in non-small cell lung cancer.
Zhang J; Zhang Y; Shen W; Fu R; Ding Z; Zhen Y; Wan Y
Biomed Pharmacother; 2019 Sep; 117():109058. PubMed ID: 31176168
[TBL] [Abstract][Full Text] [Related]
17. Loss of MiR-424-3p, not miR-424-5p, confers chemoresistance through targeting YAP1 in non-small cell lung cancer.
Zhang M; Zeng J; Zhao Z; Liu Z
Mol Carcinog; 2017 Mar; 56(3):821-832. PubMed ID: 27500472
[TBL] [Abstract][Full Text] [Related]
18. Knockdown of lncRNA MIR503HG suppresses proliferation and promotes apoptosis of non-small cell lung cancer cells by regulating miR-489-3p and miR-625-5p.
Dao R; Wudu M; Hui L; Jiang J; Xu Y; Ren H; Qiu X
Pathol Res Pract; 2020 Mar; 216(3):152823. PubMed ID: 31983569
[TBL] [Abstract][Full Text] [Related]
19. Matched Analyses of Brain Metastases versus Primary Non-Small Cell Lung Cancer Reveal a Unique microRNA Signature.
Tsakonas G; Koulouris A; Kazmierczak D; Botling J; Ortiz-Villalon C; Nord H; Lindskog M; Sandelin M; Micke P; Hydbring P; Ekman S
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613642
[TBL] [Abstract][Full Text] [Related]
20. Ginsenoside Rh2 attenuates the progression of non-small cell lung cancer by sponging miR-28-5p/STK4 axis and inactivating Wnt/β-catenin signaling.
Ma J; Zhao D; Yu D; Song W; Yang X; Yin H
Cancer Med; 2023 Jun; 12(11):12653-12667. PubMed ID: 37081781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
